Laboratories are increasingly requested to perform CYP2C19 genetic testing when managing clopidogrel therapy. especially in patients with acute coronary syndrome undergoing percutaneous coronary intervention. To ensure high quality molecular testing and ascertain that the referring clinician has the correct information for CYP2C19 genotype-directed antiplatelet therapy. a proficiency ... https://jalyttlers.shop/product-category/hurricane-lantern/